BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3516118)

  • 1. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
    Hyder DM; Schnitzer B
    Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
    Kadin ME; Muramoto L; Said J
    Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
    Hsu SM; Yang K; Jaffe ES
    Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases.
    Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD
    Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
    Coles FB; Cartun RW; Pastuszak WT
    Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells.
    Hsu SM; Hsu PL
    Am J Pathol; 1986 Feb; 122(2):223-30. PubMed ID: 3511721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
    Nguyen DT; Diamond LW; Hansmann ML; Fischer R
    Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
    Pinkus GS; Said JW
    Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of neoplasms in bone marrow biopsies using monoclonal antibodies reactive in paraffin-embedded tissue.
    Kubic VL; Brunning RD
    Mod Pathol; 1989 Nov; 2(6):618-29. PubMed ID: 2587569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.